Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …

Compared to INCS monotherapy, INCS/INAH combination therapy reduced the mean
morning and evening 12-h reflective total nasal symptom score (TNSS) more significantly …

Rhinitis—and especially allergic rhinitis (AR)—remains the most frequent hypersensitivity
condition, affecting up to a quarter of the population and impacting the quality of life of …

Allergic rhinitis (AR) is a prevalent disease in Canada that affects both children and adults.
Several guidelines for the management of AR have been published by professional allergy …

Allergic rhinitis (AR) is prevalent, and many patients present with moderate-to-severe
symptomatic disease. The majority of patients are not satisfied with their AR treatment …

Allergic rhinitis is one of the most common diseases (~ 10%–24% of the population
experience allergic rhinitis in the Russian Federation) occurring in the population regardless …

The prevalence of allergic rhinitis (AR) in children is steadily increasing, and its onset is
closely associated with genetic factors, living environment, and exposure to allergens. In …

OBJECTIVE: A retrospective study was conducted to investigate the efficacy of azelastine
nasal spray combined with mussel mucin in the treatment of allergic rhinitis (AR) and the …

Background There is insufficient systematised evidence on the effectiveness of individual
intranasal medications in allergic rhinitis (AR). Objective To perform a systematic review to …

Objective: To investigate efficacy of azelastine hydrochloride combined with montelukast
sodium in the treatment of patients with allergic rhinitis. Methods: A total of 137 patients with …